An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia
Clinical trial NCT01662310 · COMPLETED
Trial details
- NCT number
- NCT01662310
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2013-04-01
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.